MLchartDataset catalogue

piroxantrone

Term · Oncology and biomedicine · MLC-T-ONC-016092

An anthrapyrazole antineoplastic antibiotic. Piroxantrone intercalates into DNA and interacts with topoisomerase II, thereby inhibiting DNA replication and repair and RNA and protein synthesis. Although less cardiotoxic than doxorubicin, this agent exhibits a narrow spectrum of antineoplastic activity.

Table 1. Record
IdentifierMLC-T-ONC-016092
FieldOncology and biomedicine
Synonymsoxanthrazole; oxantrazole; Piroxantrone HCl
ReferencesNational Cancer Institute Thesaurus (CC BY 4.0)
Record as JSON
{
  "id": "MLC-T-ONC-016092",
  "term": "piroxantrone",
  "field": "Oncology and biomedicine",
  "definition": "An anthrapyrazole antineoplastic antibiotic. Piroxantrone intercalates into DNA and interacts with topoisomerase II, thereby inhibiting DNA replication and repair and RNA and protein synthesis. Although less cardiotoxic than doxorubicin, this agent exhibits a narrow spectrum of antineoplastic activity.",
  "synonyms": [
    "oxanthrazole",
    "oxantrazole",
    "Piroxantrone HCl"
  ],
  "references": [
    "National Cancer Institute Thesaurus"
  ],
  "url": "https://mlchart.com/terminology/oncology/piroxantrone/"
}

Record 13,281 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.